Stanford University
Showing 421-430 of 481 Results
-
Andrew D. Huberman
Associate Professor of Neurobiology and, by courtesy, of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsAndrew Huberman is a tenured associate professor of neurobiology and of ophthalmology at Stanford University School of Medicine, where he directs the Huberman Lab. After earning his B.A. from the University of California, Santa Barbara and completing M.A. and Ph.D. degrees in neuroscience at UC Berkeley and UC Davis, he conducted post-doctoral work at Stanford.
-
James Huddleston, MD
Professor of Orthopaedic Surgery
Current Research and Scholarly InterestsMy primary research interests include: arthritis, clinical outcomes of primary and revision hip and knee replacement surgery, biomaterials, the design of hip and knee implants and instrumentation, and the delivery of health services related to hip and knee replacement.
-
Louanne Hudgins
Professor of Pediatrics (Genetics) at the Lucile Salter Packard Children's Hospital, Emerita
Current Research and Scholarly InterestsI am interested in prenatal genetic screening and diagnosis.
-
Samantha Huestis
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly Interests- Employ outcomes tracking to delineate risk & resilience factors in youth with pediatric pain.
- Understand the role of peers, parents/caregivers, & systems (e.g., family, school, hospital, community) in the management of pediatric pain conditions.
- Improve functioning, behavioral health, and quality of life in youth with discomfort and their families through provision of evidence-based therapies.
- Empower families & sensitize providers to the importance of therapeutic collaborations. -
Wray Huestis
Professor of Chemistry, Emerita
BioProfessor Wray Huestis’ research concerns the molecular mechanisms whereby cells control their shape, motility, deformability and the structural integrity of their membranes. Metabolic control of interprotein and protein-lipid interactions is studied by a variety of biochemical, spectroscopic and radiochemical techniques, including fluorescence and EPR spectrometry, autoradiography and electron microscopy. The role of lipid metabolism and transport in regulating the fluid dynamics of cell suspensions (red blood cells, platelets, lymphocytes) is examined using circulating cells and cells grown in culture. Cell-cell and cell-liposome interactions are studied using model membrane systems with widely differing physical properties. Complexes of liposomes and encapsulated viruses are used as selective vectors to deliver water-soluble compounds across the membranes of intact cells. The particular projects described in the listed publications have as a common goal an understanding of the molecular workings of the cell membrane.
-
Michelle Huffaker, MD
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Michelle Huffaker is a board-certified, fellowship-trained allergist and immunologist with Stanford Health Care. She is a clinical assistant professor in the Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine at Stanford University School of Medicine.
Dr. Huffaker specializes in diagnosing and treating allergies and health conditions that affect the immune system. She is particularly interested in asthma, food allergies, and allergic rhinitis.
Dr. Huffaker’s research is focused on treatments that achieve long-lasting remission for allergic and immunologic diseases, such as food allergies and allergic rhinitis. Dr. Huffaker is the director of clinical and translational medicine for the allergy portfolio of the Immune Tolerance Network (ITN), a clinical research consortium funded by the National Institute of Allergy and Infectious Diseases (NIAID). The ITN focuses on achieving immune tolerance in conditions where the body attacks healthy cells (immune-mediated diseases). Dr. Huffaker leads the development, conduct, and analysis of ITN clinical trials.
Dr. Huffaker has published her research in peer-reviewed journals, such as Allergy, The Journal of Allergy and Clinical Immunology, and World Allergy Organization Journal. She has presented to her peers at international, national, and regional meetings, including those of the European Academy of Allergy and Clinical Immunology (EAACI), the American Academy of Allergy, Asthma, and Immunology (AAAAI), and the American College of Allergy, Asthma, and Immunology (ACAAI).
Dr. Huffaker is a fellow of AAAAI and a member of AAAAI, EAACI, and the Western Society of Allergy, Asthma, and Immunology. -
Lynne C. Huffman
Professor (Teaching) of Pediatrics (Developmental-Behavioral Pediatrics), Emerita
Current Research and Scholarly InterestsResearch interests and activities include (1) shared decision-making in clinical care; (2) medical education research; (3) the early identification and treatment of behavioral problems, particularly in children with special health care needs; and (4) community-based mental health/educational program evaluation and outcomes measurement.
-
Adrian Hugenmatter
Director of Protein Engineering
BioDr. Adrian Hugenmatter joined ChEM-H as Director of Protein Engineering in 2021. In his role, Dr. Hugenmatter heads the Protein Engineering Laboratory at the Nucleus and is responsible for the development of therapeutic proteins at the Innovative Medicines Accelerator (IMA). Dr. Hugenmatter obtained his PhD in the laboratory of Prof. Donald Hilvert at the Swiss Federal Institute of Technology in Zurich (ETH Zurich, Switzerland), where he gained initial experience in the fields of enzymology, antibody engineering and directed evolution. Fascinated by protein engineering, he moved to the laboratory of Prof. Dan Tawfik at the Weizmann Institute of Science (Israel), where he studied molecular evolution and its application in protein design. Dr. Hugenmatter then worked for more than a decade as a researcher and team leader at Roche. During this time, he was involved in the development and optimization of several antibody lead candidates for therapeutic applications in neuroscience and oncology.
